The role of CRISPR gene editing technology in correcting carcinogenic DNA changes

In 2013, a critical research discovery was made by researchers in the field of genre editing. Researchers discovered a new tool called Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). Many people hope to use CRISPR gene editing technology to eradicate genetic diseases and treat diseases such as cancer.

Ever since medical researchers discovered that changes in DNA could cause cancer, they have been searching for ways to correct these DNA defects. Although several treatments attempt to correct the DNA changes, none of them are quick, easy, or cost-effective ways to re-edit.

The new tool CRISPR has taken the research world by storm and has strikingly moved the line between possible and impossible. CRISPR gene editing technology is exceptionally convenient. Therefore, it is becoming a common method in several cancer studies.

CRISPR is inspired by nature. The idea of ​​CRISPR gene editing was borrowed from a simple defense mechanism from one of the microbes, bacteria. To protect against viruses or other invaders, bacteria capture some sections of the intruder’s DNA and store them as segments called CRISPRs.

When the same germ tries to attack that microbe again, these DNA segments help the enzyme Cas search for and cut the attacker’s DNA into slices.

After this defense system was discovered, the researchers realized that it could be a versatile gene editing tool. Within a few years, it became possible to edit multiple sections of DNA in microbial cells and then in human cells.

Why is CRISPR a Game Changer?

CRISPR changes games for the genre editing industry for many reasons, but its ease of use and relatively cheap cost are the most important among them. Previously, only a handful of laboratories developed proper tools for gene editing. But now even a high school student can make changes in complex genomes.

CRISPR can also be completely customized. It can edit virtually any segment of DNA within the three billion letters of the human genome, and it is much more accurate than other DNA editing tools of the past.

In addition, CRISPR can be quickly scaled up and is cheaper than previous methods.

Global CRISPR genre editing market

That global CRISPR genre editing market was estimated at $ 1,088.6 million in 2020, and is expected to reach $ 18,856.6 million in 2031, recording a CAGR of 29.60% in the forecast period 2021-2031.

The growth is due to the increasing demand for high quality products and nutrient enrichment in the food industry and the pharmaceutical industry for targeted treatment of various diseases. In addition, healthcare companies have increased investment in the gene editing sector to meet industry demand.

In addition, the development of gene editing technologies has enabled a greater degree of exploration in industrial areas, such as biotechnology, industrial and agricultural research. These advanced methods are cost-effective, super-efficient, simple, provide multiplexing and high throughput.

North America has the largest share of the CRISPR gene editing market due to significant investments made by biotechnology and pharmaceutical companies, increase in revenue per capita. per capita, improved health infrastructure, early availability of approved therapies and availability of advanced research laboratories and institutions in the region. Apart from this, the Asia-Pacific region is expected to grow at the fastest CAGR in the forecast period 2021-2031.

Final words

Genome editing is of great interest in the human genome. Currently, most of the research into the implementation of this method is done using therapeutic tools and animal models. Researchers are still working to determine if this approach is safe and effective for use in people with clinical conditions such as chronic diseases, cancer, heart disease, single-gene disorders, hemophilia, cystic fibrosis and others.

While the use of genome editing, such as CRISPR-Cas9, to edit human genomes is a topical ethical concern and a topic of much debate today. Currently, these are restricted to somatic cells, which are cells other than eggs and sperm. These changes only affect specific tissues and are not transmitted from one generation to another.

Changes in genes in egg or sperm can be passed on to future generations, and they therefore bring up several ethical challenges. Based on security and ethics concerns, germ cell and genetic editing is currently illegal in many countries.

Every technology has its advantages and disadvantages. It depends on human rationality as to which direction to go. Rules and regulations can help. But one must use technology for human benefit and not for destruction or change of the laws of nature.

Give a Comment